September 5, 2023 11:33 AM EDT
News Briefing

Macro­Gen­ics gets $15M from Gilead; Zenas, Bris­tol My­ers sign li­cens­ing deal in Asia-Pa­cif­ic

Anna Brown

News Reporter

Lei Lei Wu

News Reporter

Macro­Gen­ics is set to re­ceive a $15 mil­lion mile­stone pay­ment from Gilead, which is us­ing the com­pa­ny’s two bis­pe­cif­ic an­ti­body plat­forms …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times